Y10S 530/864
Monoclonal
Y10S530/864 (Monoclonal) appears on 165 US grants and 6 published applications in this corpus.
Search patents in Y10S- Granted patents
- 165
- Published applications
- 6
- Assignees
- 96
- Inventors
- 344
- Latest grant
- 4 Nov 2008
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 8 | 0 |
| 1987 | 18 | 0 |
| 1988 | 15 | 0 |
| 1989 | 24 | 0 |
| 1990 | 17 | 0 |
| 1991 | 18 | 0 |
| 1992 | 14 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 6 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 0 |
| 2002 | 6 | 2 |
| 2003 | 2 | 1 |
| 2004 | 3 | 0 |
| 2005 | 1 | 1 |
| 2006 | 1 | 0 |
| 2007 | 1 | 1 |
| 2008 | 2 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Recombinant antibodies for the detection and neutralization of anthrax toxin4 Nov 2008US 7,446,182 B1Board of Regents, The University of Texas System
- Reagent and method for detecting a Cryptosporidium parvum sporozoite antigen12 Aug 2008US 7,410,771 B2The United States of America as represented by the Department of Health and Human Services, Center for Disease Control and Prevention
- Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate2 Oct 2007US 7,276,375 B2Medical & Biological Laboratories Co., Ltd.
- Antibody methods for selectively inhibiting VEGF6 Jun 2006US 7,056,509 B2Board of Regents, The University of Texas System
- Antibody kits for selectively inhibiting VEGF3 May 2005US 6,887,468 B1Board of Regents, The University of Texas System
- Recombinant antibodies for the detection and neutralization of anthrax toxin23 Oct 2008US 2008/0262204 A1Board of Regents, The University of Texas System
- Reagent and method for detecting a cryptosporidium parvum sporozoite antigen11 Oct 2007US 2007/0238863 A1The United States of America as represented by the Department of Health and Human Services, Center for Disease Control and Prevention
- Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate4 Aug 2005US 2005/0169911 A1Medical & Biological Laboratories Co., Ltd.
- Antibody methods for selectively inhibiting VEGF18 Sep 2003US 2003/0175276 A1Board of Regents, The University of Texas System
- Antibody conjugate formulations for selectively inhibiting VEGF29 Aug 2002US 2002/0119153 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Antibody conjugates for the delivery of compounds to target sites546US 4,671,958 ACytogen Corporation · 1987
- Recombinant monoclonal antibodies385US 4,474,893 AThe University of Texas System Cancer Center · 1984
- Antibody compositions for selectively inhibiting VEGF356US 6,342,219 B12002
- Antibody-therapeutic agent conjugates288US 4,867,973 ACytogen Corporation · 1989
- Immunoassay utilizing monoclonal high affinity IgM antibodies286US 4,879,219 AThe General Hospital Corporation · 1989